Ignite Creation Date:
2024-05-05 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00562640
Status:
COMPLETED
Last Update Posted:
2023-09-15
First Post:
2007-11-21
Brief Title:
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Fludarabine Treatment Closed as of 12012009
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-21
First Submit QC Date:
November 21 2007
Study First Post Date:
2007-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-09-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-11
Last Update Post Date:
2023-09-15
Last Update Post Date Type:
ACTUAL